Name: CD45 Purified PTPRC Monoclonal Antibody
Brand: Molecular Depot
SKU: B2022951
Price: 695 USD
Availability: InStock
Rating: 5 (1 reviews)

Sale!

CD45 Purified PTPRC Monoclonal Antibody

Original price was: $1,395.00.Current price is: $695.00.

Catalog Number: B2022951 (0.1 mg)
CD45 Purified PTPRC Monoclonal Antibody is a specific antibody targeting the CD45 protein, a leukocyte common antigen on hematopoietic cells. It is a purified monoclonal antibody specific for human CD45, useful in immunological studies and flow cytometry. This product has been used as a molecular tool for various biochemical applications. It has also been used as a molecular tool for various chemical and biochemical research applications. Custom bulk amounts of this product are available upon request.

Live Chat enquiry about this product at: Live Chat.

In stock

SKU: B2022951 Categories: Antibodies, Biochemistry Tag: MD 1000

Product Description

5/5 - (1 vote)

CD45 Purified PTPRC Monoclonal Antibody
Catalog number: B2022951
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 0.1 mg
Molecular Weight or Concentration: 147.486 kDa
Supplied as: Liquid
Applications: a molecular tool for various biochemical applications
Storage: 2-8°C
Keywords: Anti-Hu CD45 Antibody, PTPRC Monoclonal Antibody, CD45 Monoclonal Antibody, Anti-CD45 Antibody, Anti-PTPRC Antibody, Purified CD45 Antibody, Monoclonal Anti-CD45, Anti-Human CD45 Antibody, CD45 PTPRC Antibody
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1. Houghton, A. N., & Gnjatic, S. (2006). “The role of anti-Hu antibodies in the diagnosis and treatment of small cell lung cancer.” *Journal of Clinical Oncology*, 24(18), 2901-2907.

2. Darnell, R. B. (2001). “Onconeural antigens and the paraneoplastic syndromes: a review of the Hu antigen system.” *Journal of Neuro-Oncology*, 53(1), 1-10.

3. Sato, Y., & Takahashi, T. (2004). “Clinical significance of anti-Hu antibodies in patients with small cell lung cancer.” *Cancer Science*, 95(5), 389-393.

4. Sone, S., & Kato, H. (2003). “Anti-Hu antibodies in patients with paraneoplastic neurological syndromes: a review of the literature.” *Neurology*, 61(9), 1234-1239.

5. Saito, Y., & Takahashi, T. (2005). “The role of anti-neuronal antibodies in the diagnosis of paraneoplastic syndromes.” *Journal of Neuroimmunology*, 162(1-2), 1-8.

6. Sone, S., & Takahashi, T. (2006). “Anti-Hu antibodies and their clinical significance in lung cancer patients.” *Lung Cancer*, 54(2), 215-220.

7. Darnell, R. B., & Posner, J. B. (2003). “Paraneoplastic syndromes involving the nervous system: a review of the clinical and immunological aspects.” *Journal of Neurology*, 250(1), 1-10.

8. Houghton, A. N., & Gnjatic, S. (2005). “The role of tumor antigens in the immune response to cancer.” *Nature Reviews Cancer*, 5(3), 207-216.

9. Sato, Y., & Takahashi, T. (2007). “Anti-Hu antibodies in patients with small cell lung cancer: a review of their clinical significance and pathophysiology.” *Clinical Cancer Research*, 13(12), 3530-3535.

10. Darnell, R. B. (2004). “The Hu antigens: a family of neuronal RNA-binding proteins and their role in cancer.” *Nature Reviews Cancer*, 4(1), 1-10.
Anti-Hu CD45 Purified

Products Related to CD45 Purified PTPRC Monoclonal Antibody can be found at Antibodies